GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹3,359 Cr | ₹2,556 Cr | ₹1,839 Cr | ₹3,771 Cr | ₹3,093 Cr |
What is the latest Cash and Bank ratio of GLAND PHARMA ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹3,359 Cr |
| Mar2025 | ₹2,556 Cr |
| Mar2024 | ₹1,839 Cr |
| Mar2023 | ₹3,771 Cr |
| Mar2022 | ₹3,093 Cr |
How is Cash and Bank of GLAND PHARMA Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,359 Cr | 31.41 | |
| Mar2025 | ₹2,556 Cr | 38.97 | |
| Mar2024 | ₹1,839 Cr | -51.22 | |
| Mar2023 | ₹3,771 Cr | 21.89 | |
| Mar2022 | ₹3,093 Cr | - | |
Compare Cash and Bank of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,224.6 Cr | -1.7% | -1.5% | 57.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.7% |
-1.5% |
57.8% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses